Prince Pharmaceutical Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	76.85	102.8	122.57	71.96	72.5	57.08
Cash & Short-Term Investments	76.85	102.8	122.57	71.96	72.5	57.08
Cash Growth	-23.36%	-16.12%	70.33%	-0.74%	27.02%	-67.40%
Accounts Receivable	148.67	116.63	108.7	72.65	62.44	57.33
Other Receivables	-	-	-	-	-	4.9
Receivables	148.67	116.63	108.7	72.65	62.44	62.23
Inventory	173.06	142.37	142.12	149.86	125.44	100.73
Prepaid Expenses	-	2.34	-	-	-	2.03
Other Current Assets	3.22	0.98	18.01	7.22	14.91	0.41
Total Current Assets	401.81	365.13	391.39	301.68	275.29	222.47
Property, Plant & Equipment	945.36	973.6	999.83	969.34	979.79	966.52
Long-Term Investments	-	-	-	-	-	5.73
Other Intangible Assets	0.7	0.45	1.3	1.51	2.02	2.59
Long-Term Deferred Tax Assets	2.29	2.29	3.83	3.26	15.85	13.24
Other Long-Term Assets	8.7	6.78	14.59	28.49	17.69	4.33
Total Assets	1,359	1,348	1,411	1,304	1,291	1,215
Accounts Payable	119.42	108.06	84.83	55.37	68.46	39.46
Accrued Expenses	-	39.98	-	-	-	21.46
Short-Term Debt	30	30	30	30	60	105
Current Portion of Long-Term Debt	32.74	32.35	31.76	31.43	16.91	6.86
Current Portion of Leases	6.96	8.07	5.01	6.97	3.19	3.69
Current Income Taxes Payable	4.44	-	4.35	-	-	-
Current Unearned Revenue	3.75	5.45	2.62	14.78	10.91	8.39
Other Current Liabilities	48.75	10.81	53.38	51.61	41.67	9.8
Total Current Liabilities	246.06	234.71	211.94	190.16	201.14	194.66
Long-Term Debt	250.8	267.27	299.49	330.92	362.06	309.91
Long-Term Leases	120.21	123.11	124.1	123.78	123.83	99.52
Long-Term Deferred Tax Liabilities	1.1	1.1	0.93	1.05	0.74	0.02
Total Liabilities	618.17	626.19	636.47	645.91	687.77	604.1
Common Stock	366.05	366.05	361.93	331.93	331.93	331.93
Additional Paid-In Capital	356.87	363.93	348.49	282.22	279.29	279.29
Retained Earnings	17.77	-7.92	53.81	44.23	-8.36	-0.45
Comprehensive Income & Other	-	-	10.24	-	-	-
Shareholders' Equity	740.69	722.06	774.47	658.38	602.87	610.77
Total Liabilities & Equity	1,359	1,348	1,411	1,304	1,291	1,215
Total Debt	440.71	460.8	490.36	523.11	565.99	524.97
Net Cash (Debt)	-363.86	-357.99	-367.79	-451.15	-493.49	-467.89
Net Cash Per Share	-9.94	-9.79	-10.06	-13.54	-14.87	-14.30
Filing Date Shares Outstanding	36.61	36.61	36.19	33.19	33.19	33.19
Total Common Shares Outstanding	36.61	36.61	36.19	33.19	33.19	33.19
Working Capital	155.74	130.42	179.45	111.52	74.15	27.81
Book Value Per Share	20.23	19.73	21.40	19.83	18.16	18.40
Tangible Book Value	739.99	721.61	773.16	656.86	600.85	608.18
Tangible Book Value Per Share	20.22	19.71	21.36	19.79	18.10	18.32
Land	102.92	102.92	102.92	102.92	102.92	102.92
Buildings	580.78	580.78	580.78	578.84	578.62	578.27
Machinery	465.17	462.94	441.82	365.91	336.1	313.48

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.